SLS Borrow Market Scarcity
SELLAS Life Sciences Group (SLS) is currently flagged for having exceptionally high borrow fees. This is a classic indicator of a 'hard-to-borrow' stock, where the supply of shares available for shorting has been depleted. When borrow fees spike, it often forces short sellers to reconsider their positions or pay a premium to maintain them. This environment can lead to rapid price movements if a catalyst triggers a short covering event. Market participants should monitor the availability of shares on the lending desk to gauge if the squeeze risk is increasing.
Signal data sourced from Interactive Brokers. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.